For its first fiscal quarter (ending December 31), Dolby Laboratories Inc (NYSE: DLB) has reported a 1% increase in E.P.S. from $0.70 a year ago to $0.71 in the current quarter. E.P.S. were $2.74 for the latest four quarters through December 31 versus $1.97 for the same period a year ago — an increase of 39%.
Recent Price Action
On 1/29/25, Dolby Laboratories Inc (NYSE: DLB) stock rose slightly by 0.02%, closing at $80.63. However, trading volume in this advance was below average at 81% of normal. The stock has declined -1.0% during the last week and has performed in line with the market over the last nine months.
Current PriceTarget Research Rating
Dolby Laboratories has a current Value Trend Rating of D (Negative). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing inconsistent signals. Dolby Laboratories has a neutral Power Rating of 44 but a poor Appreciation Score of 25, and the Negative Value Trend Rating results.
Rating Review
In light of this new information we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment